Sponsors (5)
The bill directs multi-year federal funding to study and target maternal mortality—potentially reducing deaths and narrowing disparities over time—but requires taxpayer funding and may take years to produce measurable local improvements while raising allocation and implementation risks.
Pregnant and postpartum people (especially in high-risk regions) will get sustained, targeted research and evidence-building—backed by $73.4M/year—to inform interventions that can reduce preventable maternal deaths and severe maternal morbidity.
Communities with disproportionately high maternal mortality (including racial/ethnic minorities and low-income populations) will receive community-based interventions and evaluation designed to reduce disparities in maternal outcomes.
Pregnant people and maternal-health stakeholders gain a clear, recognizable name for the law, which can improve awareness, program identification, and stakeholder communication.
Taxpayers will fund an ongoing federal commitment of $73.4M annually from FY2026–2031 to support the initiative.
Pregnant and postpartum people may not see immediate reductions in maternal mortality because research grants and program funding can take time to translate into measurable health outcomes.
If funding prioritizes research over on-the-ground implementation, local clinics and hospitals—particularly those serving low-income communities—may lack sufficient operational support to change care quickly.
Based on analysis of 2 sections of legislative text.
Creates an NIH initiative to fund research and community interventions to reduce preventable maternal mortality, severe maternal morbidity, and disparities, with $73.4M/year authorized for FY2026–2031.
Introduced November 20, 2025 by Lauren Underwood · Last progress November 20, 2025
Creates a new NIH initiative to improve maternal health by funding and coordinating research, community-based interventions, and evaluation aimed at reducing preventable maternal deaths, severe maternal health complications, and the disparities that lead to worse outcomes for some groups. The NIH Director may award grants, contracts, cooperative agreements, or other transactions to run the program. Authorizes $73,400,000 per year for fiscal years 2026 through 2031 to carry out the initiative; this is an authorization of funding (actual spending requires separate appropriation action).